Status:
TERMINATED
Critical Congenital Heart Defect (CHD) Outcomes in Children
Lead Sponsor:
Emory University
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
1-21 years
Brief Summary
Congenital heart disease in infants and children often challenges healthcare providers both in regards to diagnosis and in the management of these conditions. The field becomes more complicated as one...
Detailed Description
Patients, age newborn to 21 years, followed in the High Risk Congenital Heart Defect Clinic at Children's Healthcare of Atlanta at Egleston will be asked to participate in this trial. The term "high r...
Eligibility Criteria
Inclusion
- Critical congenital heart disease
- Signed informed consent
Exclusion
- Not diagnosed with critical congenital heart disease
- No signed informed consent
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00208689
Start Date
January 1 2004
Last Update
February 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322